RESEARCH PHARMACEUTICAL SERVICES, INC.·4

Aug 10, 4:31 PM ET

Bell Steven 4

4 · RESEARCH PHARMACEUTICAL SERVICES, INC. · Filed Aug 10, 2010

Insider Transaction Report

Form 4
Period: 2010-08-04
Bell Steven
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2010-08-09+100,000100,000 total
    Exercise: $0.00Exp: 2020-08-09Common Stock (100,000 underlying)
  • Award

    Common Stock

    2010-08-09+40,000215,705 total
Footnotes (2)
  • [F1]This amount represents the par value per underlying share of common stock. The exercise price per share equals the fair market value of a share of common stock as of the grant date, August 9, 2010, which will be determined by an independent valuation to be completed following the grant date.
  • [F2]One-third of the option becomes vested and exercisable on August 9, 2011, and 8.33% of the option vests and becomes exercisable every 90 days thereafter until the option becomes fully vested and exercisable.

Documents

1 file
  • 4
    c04718_4x0.xmlPrimary

    MAIN DOCUMENT DESCRIPTION